VALSA JOHN: Open Payments
NPI 1700955481 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 21 payments from 12 companies in 2025. Trend: 2023 $581 · 2024 $547 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $305 |
| Abbott Laboratories | 1 | $193 |
| ABBVIE INC. | 3 | $87 |
| Novo Nordisk Inc | 3 | $66 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Amgen Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
Products named: BREZTRI, FREESTYLE LIBRE 3, UBRELVY, ZORYVE, AIRSUPRA, LINZESS, KRYSTEXXA, Ozempic.
Industry payments across NY — which companies pay providers there.
